Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Semax structure

Semax

Cognitive
Phase 3 Research
60%
Low Risk
1/5

Dosing Protocol

Typical Dose 600 mcg
Range 200 - 900 mcg
Maintenance 600 mcg 2-3x daily

Pharmacokinetics

Half-Life 25 min
Onset 2 min
Peak 10 min
Duration 4.0 hrs
Bioavailability 95%
Primary Route Nasal

Administration

Routes Nasal, Subcutaneous
Syringe Type Nasal Spray
Timing Morning, afternoon

Reconstitution

Diluent Bacteriostatic Water
Volume 3 mL
Concentration 1667 mcg/mL
Stability 30 days refrigerated
Vial Sizes 5 mg

Special Instructions

Nasal spray preferred. Used clinically in Russia for stroke recovery. Can enhance focus and mental clarity.